Research Notes

Gene therapy approaches for Parkinson’s disease aim to modify or supplement gene expression to restore dopamine signaling, protect neurons, or modulate disease pathways. Recent advances show improved vector delivery, better safety profiles, and early signals of clinical benefit, though challenges remain around long-term efficacy, targeting, and scalability. Alzheimer’s & Neurodegeneration …

Healthspan Is Becoming Real: What the GLP-1 Shift Means Healthspan Is Becoming Real: What the GLP-1 Shift Means At a leading aging research meeting, major drug makers described GLP-1 medicines as “longevity therapeutics.” That language shift matters: it opens the door to earlier prevention trials, better biomarkers, and treatments that …